Selected article for: "current knowledge and RNA replication"

Author: Abdul-Cader, Mohamed Sarjoon; Amarasinghe, Aruna; Abdul-Careem, Mohamed Faizal
Title: Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses
  • Cord-id: 8mivdnt0
  • Document date: 2016_5_27
  • ID: 8mivdnt0
    Snippet: Toll-like receptors (TLRs), well-characterized pattern-recognizing receptors of the innate arm of the immune system, are vital in detecting pathogen-associated molecular patterns (PAMPs). The TLR-PAMP interaction initiates an intracellular signaling cascade, predominantly culminating in upregulation of antiviral components, including inducible nitric oxide synthase (iNOS). After activation, various TLR pathways can promote iNOS production via the myeloid differentiation primary response-88 (MyD-
    Document: Toll-like receptors (TLRs), well-characterized pattern-recognizing receptors of the innate arm of the immune system, are vital in detecting pathogen-associated molecular patterns (PAMPs). The TLR-PAMP interaction initiates an intracellular signaling cascade, predominantly culminating in upregulation of antiviral components, including inducible nitric oxide synthase (iNOS). After activation, various TLR pathways can promote iNOS production via the myeloid differentiation primary response-88 (MyD-88) adapter protein. Subsequently, iNOS facilitates production of nitric oxide (NO), a highly reactive and potent antiviral molecule that can inhibit replication of RNA and DNA viruses. Furthermore, NO can diffuse freely across cell membranes and elicit antiviral mechanisms in various ways, including direct and indirect damage to viral genomes. This review emphasizes current knowledge of NO-mediated antiviral responses elicited after activation of TLR signaling pathways.

    Search related documents:
    Co phrase search for related documents
    • acid component and lps lipopolysaccharide: 1
    • acid component and macrophage cell line: 1
    • activation lead and lps lipopolysaccharide: 1, 2
    • activation phosphorylation and adaptor protein: 1, 2, 3, 4
    • activation phosphorylation and lps lipopolysaccharide: 1, 2, 3, 4, 5
    • activation phosphorylation and lps signaling: 1
    • activator protein and adaptor molecule: 1
    • activator protein and adaptor protein: 1, 2, 3
    • activator protein and additive effect: 1
    • activator protein and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7
    • activator protein and lps signaling: 1
    • activator protein and lung viral load: 1
    • activator protein and macrophage cell line: 1, 2